2024 ´ëÇÑÇ÷¾×ÇÐȸ CML¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö : 2024-01-27
±³À°ÀÏÀÚ : 2024-01-27
±³À°Àå¼Ò : ÇѾç´ëÇб³ HIT ´ëȸÀǽÇ
±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ CML¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¸¸¼º°ñ¼ö¼º¹éÇ÷º´¿¬±¸È¸
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ : hematology@kams.
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í ºñȸ¿ø 50,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01¿ù 27ÀÏ ´ëȸÀÇ½Ç 09:20~09:40 Accelerated phase CML(chronic myeloid leukemia)-de Novo and Transformed ¾ç½Â¾Æ(°¡Å縯ÀÇ´ë )
±³À°½Ã°£ 01¿ù 27ÀÏ ´ëȸÀÇ½Ç 09:40~10:00 Resistance Mutations in CML(chronic myeloid leukemia) and How We Approach Them Á¤Á¾Çå(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 01¿ù 27ÀÏ ´ëȸÀÇ½Ç 10:00~10:20 Atypical CML(chronic myeloid leukemia)-Diagnosis and Treatment ¾öÁöÀº(ÇѾçÀÇ´ë )
±³À°½Ã°£ 01¿ù 27ÀÏ ´ëȸÀÇ½Ç 10:40~11:20 Oncogenic drivers and genetic models in CML(chronic myeloid leukemia) À̼¼¿ø(ÀÌÈÀÇ´ë )
±³À°½Ã°£ 01¿ù 27ÀÏ ´ëȸÀÇ½Ç 11:20~12:00 Treatment-Free Remission in CML(chronic myeloid leukemia) ÀÓ¼º³²(ÀÎÁ¦ÀÇ´ë )
±³À°½Ã°£ 01¿ù 27ÀÏ ´ëȸÀÇ½Ç 12:00~12:40 Novel therapeutic approaches in CML(chronic myeloid leukemia) ¹Ú¿µ¼·(¿µ³²ÀÇ´ë )